Article Details
Retrieved on: 2023-01-09 19:23:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca has committed $1.3 billion to acquire CinCor Pharma, a clinical-stage biotech whose lead drug candidate has the potential to treat ...
Article found on: medcitynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here